# Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

> **NCT00305396** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 80 (—)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00305396
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305396, "Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00305396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*